Diabetic macular edema: current and emerging therapies

Middle East Afr J Ophthalmol. 2012 Jan;19(1):4-12. doi: 10.4103/0974-9233.92110.

Abstract

Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.

Keywords: Diabetic Macular Edema; Focal/Grid Photocoagulation; Intravitreal Corticosteroids.